account3 billion. The stock sells for 8.8 times estimated profit, making it the second-cheapest of 10 global drug companies of similar size. Only AstraZeneca Plc is cheaper. ���The perception of Teva changed massively over the past year, from a company which...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Teva���s U.S. Generic-Drug Sales Tumble on Factory Problems
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account